Clinical Trial

Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study will evaluate patient-reported outcomes before and after percutaneous ablation of desmoid tumors. Adult participants undergoing ablation for desmoid tumor will complete surveys pre and post procedure to assess symptom burden, impact on daily life, early post-procedural pain and recovery, concomitant treatments, and radiological response following ablation.
Trial Details
NCT Number NCT07755176
Lead Sponsor Mayo Clinic
Conditions Desmoid Tumor, Aggressive Fibromatoses
Enrollment 30 participants
Start Date 2026-09-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10